跳至主要内容
临床试验/CTIS2023-508325-27-00
CTIS2023-508325-27-00进行中(未招募)1 期

APO - Novel Approach for Oligospermia

Herlev Hospital0 个研究点目标入组 60 人开始时间: 2023年9月20日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
Male

入选标准

  • Infertile men >18 years and <60 years of age with reduced sperm production (Sperm concentration <2 mio/mL) - Serum AMH > 30 pmol/

排除标准

  • Men with chronic diseases (diabetes mellitus, thyroid disease, endocrine diseases requirering treatment such as sarcoidosis, tuberculosis, wegeners, vasculitis as well as inflammatory bowel diseases e.g. chron's disease or ulcerative colitis etc), Latex allergy, Any case with indication for testis biopsy, Serum FSH <3 IU/L, BMI >35 kg/m^2, Men with active or previous malignant disease, Sperm cell concentration <0.01 mio/mL, Men in treatment for osteoporosis, Serum ionized calcium < 1,18 mmol/L, Total calcium < 2.14 mmol/L or Albumin corrected calcium <2.17 mmol/L, Serum 25OHD < 25 nmol/L, eGFR <60 mL/min/1.73m^2, Poor dental status og dental implants, Men with obstructive oligospermia (Sperm volume <0.9 mL) or who has been vasectomized

研究者

相似试验